High-Intensity Interval Exercise for Insulin Sensitivity
Trial Summary
Do I have to stop taking my current medications for the trial?
Yes, you must stop taking medications for managing blood glucose or lipid metabolism, oral contraceptives, and medications affecting substrate metabolism like corticosteroids or nSAIDs.
What data supports the idea that High-Intensity Interval Exercise for Insulin Sensitivity is an effective treatment?
The available research shows that High-Intensity Interval Exercise (HIIT) is effective in improving insulin sensitivity. One study found that after 12 weeks, both HIIT and Sprint Interval Training (SIT) improved insulin sensitivity by about 26% and 39%, respectively, while moderate-intensity continuous training (MICT) did not show any improvement. Another study highlighted that HIIT and SIT can improve glycemic control, which is important for managing conditions like type 2 diabetes, in less time compared to traditional aerobic exercise. This makes HIIT a time-efficient and effective treatment for improving insulin sensitivity.12345
What safety data exists for high-intensity interval exercise?
High-intensity interval exercise (HIIE) has been studied for safety in various populations, including those with cardiovascular and metabolic diseases, older adults, and patients with cardiovascular disease. A systematic review found that HIIE can have a higher rate of adverse responses (~8%) in patients with cardiometabolic diseases compared to moderate-intensity exercise, suggesting the need for caution and supervision. In older adults, HIIT was generally well-tolerated, though more research is needed. For patients with cardiovascular disease, HIIT showed a low rate of major adverse cardiovascular events when applied in cardiac rehabilitation settings, with one major event per 17,083 training sessions. Overall, while HIIE can be safe, it requires careful monitoring, especially in clinical populations.16789
Is high-intensity interval exercise a promising treatment for improving insulin sensitivity?
What is the purpose of this trial?
High-intensity interval exercise (HIIE) is a type of exercise that involves alternating periods of intense exercise with periods of rest. HIIE has been shown to improve many aspects of cardiovascular and metabolic health in a time-efficient manner (e.g., only 20 minutes per exercise session). An important health benefit of exercise is improved blood sugar control, which can help reduce the risk of metabolic diseases like type 2 diabetes. A single session of HIIE has been shown to improve blood sugar in males, but it is unknown if females achieve the same health benefit. It is also not fully understood how exercise improves blood sugar in males and females. Therefore, the purpose of this project is 1) to determine if a single session of HIIE improves blood sugar control in males and females, and 2) to evaluate if changes in skeletal muscle can explain the beneficial effects of HIIE on blood sugar.
Research Team
Stephanie Estafanos, MSc
Principal Investigator
University of Toronto
Eligibility Criteria
This trial is for healthy, non-smoking men and women aged 18-35 with a BMI of 18-27 who are moderately active but not training for sports. Women must have regular menstrual cycles and can't be using oral contraceptives or be pregnant. Participants should not have metabolic diseases, be on blood glucose medications, or follow low-carb diets.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Measurement
Participants' insulin sensitivity and muscle outcomes are measured following 30 minutes of sitting in the lab
Exercise Intervention
Participants undergo a single session of high-intensity interval exercise (HIIE) on a stationary bike
Post-exercise Measurement
Insulin sensitivity and muscle outcomes are measured after the exercise session
Follow-up
Participants are monitored for safety and effectiveness after the exercise intervention
Treatment Details
Interventions
- High-intensity interval exercise
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Toronto
Lead Sponsor